DOT Marijuana Employment Rules: Federal Testing Requirements Explained

Executive Summary

The U.S. Department of Transportation maintains a zero-tolerance policy for marijuana use among safety-sensitive transportation workers, regardless of state legalization laws. This federal mandate applies to approximately 12.5 million employees across aviation, trucking, rail, transit, pipeline, and maritime sectors who are subject to DOT drug testing regulations under 49 CFR Part 40. Despite medical and recreational marijuana legalization in 38 states and Washington D.C. as of May 2026, DOT-regulated employers must continue to test for THC and terminate or disqualify employees who test positive, even when cannabis use is legal under state law. The policy creates a stark conflict between state-level reforms and federal workplace safety requirements, affecting flight attendants, pilots, commercial truck drivers, train engineers, and other transportation professionals who face career-ending consequences for off-duty marijuana consumption that would be lawful for other workers in their states. Recent DOT clarifications in May 2026 reaffirmed this position following inquiries from labor unions and employers seeking guidance as state legalization expands.

Why This Matters

DOT marijuana employment rules affect more than 12.5 million American workers in safety-sensitive transportation positions who cannot use cannabis even when off-duty and living in legalized states. The policy's reach extends across commercial aviation (pilots, flight attendants, mechanics, air traffic controllers), trucking (CDL holders operating vehicles over 26,001 pounds), railroads (engineers, conductors, dispatchers), mass transit (bus and subway operators), pipelines, and maritime operations. These workers face immediate disqualification from safety-sensitive duties following a positive drug test, typically resulting in termination or mandatory substance abuse treatment programs before potential reinstatement. The economic stakes are substantial. The American Trucking Associations reported in 2025 that the industry faces a shortage of approximately 78,000 drivers, with drug testing failures contributing to recruitment and retention challenges. Airlines and freight carriers have documented difficulty filling positions as younger workers increasingly view marijuana restrictions as outdated, particularly when alcohol consumption remains permissible during off-duty hours. The Federal Motor Carrier Safety Administration reported 55,582 positive marijuana tests among commercial drivers in 2024, a 12% increase from 2023, representing both increased use and improved detection methods. Labor unions representing transportation workers, including the Association of Flight Attendants-CWA, Transport Workers Union, and International Brotherhood of Teamsters, have advocated for policy reforms that would allow off-duty marijuana use in legalized states while maintaining strict prohibitions on impairment during work hours. These organizations argue that current rules create an unjust two-tier system where transportation workers are denied legal rights available to other citizens, affecting recruitment, retention, and worker morale across the sector.

Background and History

Federal marijuana testing requirements for transportation workers originated with the Anti-Drug Abuse Act of 1988 and were codified through DOT regulations implemented in the 1990s.

Legislative Foundation (1988-1991)

The Anti-Drug Abuse Act of 1988 (Public Law 100-690) mandated drug-free workplace programs for federal contractors and established the framework for transportation industry testing. Congress directed the Department of Transportation to develop regulations ensuring that employees in safety-sensitive positions were not impaired by controlled substances. The Omnibus Transportation Employee Testing Act of 1991 (Public Law 102-143) specifically required DOT to implement drug and alcohol testing programs across all transportation modes, establishing the regulatory structure that remains in force today.

Initial Regulatory Implementation (1994-2000)

DOT published final rules in 49 CFR Part 40 in December 1994, establishing standardized procedures for drug and alcohol testing across aviation, motor carrier, railroad, transit, pipeline, and maritime sectors. The regulations required pre-employment testing, random testing (at minimum annual rates of 50% for drugs and 10% for alcohol), post-accident testing, reasonable suspicion testing, return-to-duty testing, and follow-up testing. Marijuana was included in the mandatory five-panel drug test alongside cocaine, amphetamines, opiates, and phencyclidine (PCP), with a cutoff level of 50 ng/mL for THC metabolites in urine samples. The Federal Aviation Administration implemented 14 CFR Part 120 for aviation employees, the Federal Motor Carrier Safety Administration established 49 CFR Part 382 for commercial drivers, and the Federal Railroad Administration created 49 CFR Part 219 for railroad workers. Each modal administration developed specific rules within the Part 40 framework, but all maintained identical marijuana testing requirements and consequences.

State Medical Marijuana Era (1996-2012)

California became the first state to legalize medical marijuana through Proposition 215 in November 1996, creating immediate tension with federal transportation rules. DOT issued guidance in 1997 clarifying that state medical marijuana laws provided no exception to federal testing requirements. The agency emphasized that the Controlled Substances Act classified marijuana as a Schedule I substance under 21 U.S.C. § 812, and DOT regulations must comply with federal law regardless of state reforms. As additional states adopted medical marijuana programs—Alaska and Oregon in 1998, Maine in 1999, Colorado, Hawaii, and Nevada in 2000—DOT consistently maintained its position. A 2009 DOT memorandum stated that "medical marijuana use is not a valid medical explanation for a positive drug test result" and that Medical Review Officers (MROs) must report positive marijuana tests as violations even when employees present valid state medical marijuana cards.

Recreational Legalization and Increased Conflict (2012-2020)

Colorado and Washington became the first states to legalize recreational marijuana in November 2012, with sales beginning in 2014. DOT issued updated guidance in 2012 reaffirming that state recreational laws did not alter federal testing obligations. The Federal Motor Carrier Safety Administration published a specific notice in the Federal Register (79 FR 62854) in October 2014 stating that commercial drivers could not use marijuana regardless of state law and that employers must continue testing and disqualifying drivers who test positive. By 2020, 11 states had legalized recreational marijuana and 33 had medical programs. The conflict intensified as mainstream acceptance of cannabis grew while DOT maintained unchanged policies. The agency faced increasing pressure from labor organizations, state governments, and industry groups to modernize rules, but consistently cited federal law constraints and safety concerns as barriers to reform.

Recent Developments (2021-2026)

The DOT published revised Part 40 regulations in January 2023 updating laboratory procedures and Medical Review Officer protocols but maintaining all marijuana testing requirements. The Federal Aviation Administration issued a notice in March 2024 reminding aviation employers that CBD products could cause positive THC tests and that employees using such products did so at their own risk, with no exception for inadvertent exposure. In May 2026, following inquiries from the Association of Flight Attendants-CWA and other labor organizations, DOT issued clarifying guidance reaffirming that state marijuana laws—whether medical or recreational—provide no basis for employees to contest positive drug tests or for employers to decline testing or termination actions. The guidance emphasized that 49 CFR Part 40 requirements are mandatory and that employers who fail to comply risk federal enforcement action, including loss of operating authority.

Key Players

Department of Transportation

The DOT Office of Drug and Alcohol Policy and Compliance (ODAPC) administers the federal drug testing program and issues authoritative guidance to employers, employees, and testing facilities. ODAPC Director Patrice Kelley has consistently stated that the agency lacks authority to modify marijuana testing requirements without Congressional action or DEA rescheduling of cannabis under the Controlled Substances Act. The office maintains that safety considerations—not criminal justice policy—drive testing requirements, and that no reliable roadside or workplace impairment test for marijuana currently exists to replace urine testing for THC metabolites.

Federal Aviation Administration

The FAA regulates approximately 900,000 safety-sensitive aviation workers under 14 CFR Part 120, including pilots, flight attendants, aircraft mechanics, air traffic controllers, and ground security coordinators. The agency maintains the most stringent position on marijuana among DOT modal administrations, citing the critical safety implications of aviation operations. FAA medical certification standards prohibit marijuana use for all airmen holding medical certificates, creating dual restrictions—both employment-based and medical certification-based—for pilots and other certificated personnel.

Federal Motor Carrier Safety Administration

FMCSA oversees drug testing for approximately 7.5 million commercial driver's license holders operating vehicles in interstate commerce. The agency administers the Drug and Alcohol Clearinghouse, a database established in January 2020 that tracks all CDL holders who test positive for drugs or alcohol, refuse testing, or complete return-to-duty processes. As of April 2026, the Clearinghouse contained records for 187,432 drivers with marijuana violations, representing 68% of all drug testing violations in the database. FMCSA regulations prohibit drivers from operating commercial vehicles until they complete a substance abuse professional evaluation and return-to-duty testing following a positive marijuana test.

Federal Railroad Administration

The FRA regulates drug testing for approximately 120,000 railroad employees in safety-sensitive positions under 49 CFR Part 219. The agency requires post-accident testing following significant incidents and maintains authority to conduct unannounced testing at railroad facilities. FRA has documented marijuana as the most frequently detected drug in post-accident testing, appearing in approximately 8% of tests following serious rail incidents in 2024.

Association of Flight Attendants-CWA

The AFA-CWA represents 50,000 flight attendants at 19 airlines and has been a vocal advocate for marijuana policy reform. The union argues that current rules are inconsistent with alcohol policies, which permit off-duty consumption provided employees report to work sober and below the 0.04% blood alcohol threshold. AFA-CWA has called for DOT to develop marijuana impairment testing that would prohibit on-duty use while permitting off-duty consumption in legalized states, similar to alcohol regulations. The union's May 2026 communication to members acknowledged DOT's clarification while expressing continued advocacy for policy modernization.

International Brotherhood of Teamsters

The Teamsters represent approximately 600,000 workers in transportation and logistics, including many CDL holders subject to FMCSA testing. The union has filed grievances on behalf of members terminated for marijuana use in legalized states, arguing that off-duty conduct should not be grounds for termination when legal under state law. These grievances have been consistently denied by arbitrators who cite federal law supremacy and the explicit requirements of 49 CFR Part 382.

Commercial Carriers and Employers

Major airlines, trucking companies, railroads, and transit agencies have uniformly maintained marijuana testing and termination policies in compliance with DOT regulations, despite state legalization. Companies including United Airlines, FedEx, Union Pacific Railroad, and major transit agencies have stated they have no discretion to modify policies while DOT regulations remain in effect. Some employers have reported recruitment challenges, particularly for commercial driving positions, as younger applicants decline to pursue careers with permanent marijuana restrictions.

Legal and Regulatory Framework

DOT marijuana employment rules rest on federal statutory authority that preempts state law, creating an unambiguous legal hierarchy that courts have consistently upheld. The Controlled Substances Act, codified at 21 U.S.C. § 801 et seq., classifies marijuana as a Schedule I controlled substance, defined as having high abuse potential, no currently accepted medical use, and lack of accepted safety for use under medical supervision. This classification, established in 1970 and maintained through 2026 despite ongoing DEA review processes, provides the foundation for federal workplace drug policies. The Omnibus Transportation Employee Testing Act of 1991 (49 U.S.C. § 20140 for railroads, 49 U.S.C. § 31306 for commercial motor vehicles, 49 U.S.C. § 45102 for aviation) mandates that DOT establish testing programs to ensure transportation employees are not impaired by controlled substances. The statute requires testing for marijuana specifically and does not grant DOT discretion to exempt state-legal use. DOT regulations at 49 CFR Part 40 establish uniform procedures for drug testing across all transportation modes. Section 40.151 specifies that Medical Review Officers must report marijuana tests above 50 ng/mL as positive, with no exception for medical marijuana cards or state legalization. Section 40.25 prohibits employers from implementing policies less stringent than Part 40 requirements, preventing companies from adopting marijuana-tolerant policies even if they wished to do so. Modal-specific regulations impose additional requirements. FMCSA's 49 CFR § 382.213 prohibits commercial drivers from using marijuana and requires employers to remove drivers from safety-sensitive functions immediately upon receiving notice of a positive test. FAA's 14 CFR § 120.109 requires aviation employers to implement anti-drug programs that test for marijuana. FRA's 49 CFR § 219.101 mandates post-accident testing for marijuana following significant rail incidents. The Supremacy Clause of the U.S. Constitution (Article VI, Clause 2) establishes that federal law supersedes conflicting state law. Federal courts have consistently held that state marijuana legalization does not create employee rights to use cannabis when federal law or federal regulations prohibit such use. In Coats v. Dish Network, LLC (Colorado Supreme Court, 2015), the court ruled that Colorado's lawful off-duty activities statute did not protect medical marijuana use because marijuana remains illegal under federal law, making the activity not "lawful" within the statute's meaning. DOT-regulated employees have challenged terminations for marijuana use through various legal theories, all unsuccessful. Claims under the Americans with Disabilities Act have failed because the ADA explicitly excludes current illegal drug use from protection (42 U.S.C. § 12114), and marijuana remains federally illegal regardless of state law. State disability discrimination claims have similarly failed, with courts holding that employers need not accommodate medical marijuana use when doing so would violate federal law or regulations.

Impact on Transportation Sectors

DOT marijuana rules create distinct operational and workforce challenges across aviation, trucking, rail, and transit sectors, with each industry experiencing unique pressures from the federal-state law conflict.

Aviation Industry

The aviation sector faces the most restrictive marijuana environment due to overlapping DOT employment rules and FAA medical certification requirements. Pilots holding first, second, or third-class medical certificates must disclose marijuana use to Aviation Medical Examiners, and such use results in medical certificate denial or revocation under 14 CFR § 67.307. Flight attendants, while not requiring medical certificates, are subject to 14 CFR Part 120 testing requirements and face immediate termination following positive tests. Airlines reported 1,247 positive marijuana tests among safety-sensitive employees in 2024, according to FAA data, representing a 23% increase from 2019. The Air Line Pilots Association has noted that younger pilot candidates increasingly question marijuana policies during recruitment, viewing them as inconsistent with alcohol rules and state legalization trends. Regional airlines facing pilot shortages have reported losing candidates who decline to pursue aviation careers due to permanent marijuana restrictions.

Trucking and Motor Carrier Industry

The commercial trucking sector has experienced the most significant workforce impact from marijuana testing. FMCSA's Drug and Alcohol Clearinghouse data shows that marijuana violations account for 68% of all drug testing failures among CDL holders, with 55,582 positive marijuana tests recorded in 2024. The American Trucking Associations estimated that approximately 88,000 CDL applicants failed pre-employment drug tests in 2024, with marijuana representing the majority of failures. The clearinghouse requirement, which mandates that employers check driver records before hiring, has created a permanent barrier for drivers with marijuana violations. Drivers must complete substance abuse professional evaluations, treatment programs, and return-to-duty testing before clearinghouse records can be resolved, a process typically requiring 6-12 months and costing $2,000-$5,000. Many drivers with marijuana violations exit the industry rather than complete this process, exacerbating driver shortages. Trucking companies operating in states with legal marijuana have reported particular challenges. Drivers residing in California, Colorado, Oregon, and other legalized states may legally purchase and consume cannabis but face career-ending consequences if tested. Companies have documented cases of experienced drivers with clean safety records terminated for off-duty marijuana use that would be legal for non-CDL holders in their states.

Railroad Industry

Railroad operations face stringent post-accident testing requirements under 49 CFR Part 219, which mandate marijuana testing following accidents involving fatalities, injuries requiring medical treatment, or property damage exceeding specified thresholds. FRA data from 2024 showed marijuana detected in 8.2% of post-accident tests, though the agency notes that marijuana detection indicates prior use, not necessarily impairment at the time of the accident due to THC's long detection window in urine tests. Railroad unions have challenged the relevance of marijuana testing given that THC metabolites can be detected 3-30 days after use, meaning positive post-accident tests may reflect off-duty use weeks before an incident. The Federal Railroad Administration has maintained that testing serves both deterrent and detection purposes and that no alternative testing method currently exists that reliably indicates recent use or impairment.

Transit Systems

Public transit agencies operating buses, subways, and light rail systems under Federal Transit Administration oversight must comply with 49 CFR Part 655 drug testing requirements. Transit agencies in states with legal marijuana have faced particular public scrutiny when operators test positive following accidents, even when marijuana was not determined to be a causal factor. The Washington Metropolitan Area Transit Authority, serving Washington D.C., Maryland, and Virginia, reported 47 positive marijuana tests among safety-sensitive employees in 2024. The agency faced criticism from both sides—advocates arguing that off-duty use should be permitted in D.C. where marijuana is legal, and safety groups contending that any marijuana use by transit operators is unacceptable. Similar debates have occurred in Denver, Seattle, Portland, and other cities with both legal marijuana and significant transit systems.

State-by-State Legal Landscape

Thirty-eight states and Washington D.C. have legalized medical or recreational marijuana as of May 2026, but none provide protection for DOT-regulated transportation workers.

California

California legalized medical marijuana in 1996 and recreational marijuana in 2016 through Proposition 64. The state's employment protections for marijuana use are limited; California law does not require employers to accommodate marijuana use, and courts have held that employers may terminate employees for off-duty marijuana consumption. For DOT-regulated workers, California employers must comply with federal testing requirements regardless of state legalization. The California Trucking Association has estimated that 12% of CDL applicants in the state fail pre-employment drug tests, primarily for marijuana.

Colorado

Colorado legalized medical marijuana in 2000 and recreational marijuana in 2012, becoming a national model for regulated cannabis markets. However, Colorado's Lawful Off-Duty Activities Statute (C.R.S. § 24-34-402.5) has been interpreted by courts not to protect marijuana use because cannabis remains federally illegal. In Coats v. Dish Network, the Colorado Supreme Court ruled that "lawful" means lawful under both state and federal law. DOT-regulated employers in Colorado continue mandatory marijuana testing, with the Colorado Department of Transportation reporting 892 positive tests among commercial drivers in 2024.

Washington

Washington legalized recreational marijuana in 2012 alongside Colorado. The state's employment laws do not protect marijuana use, and Washington courts have held that employers may enforce drug-free workplace policies that include marijuana. The Washington State Department of Transportation, which employs CDL holders and transit operators, maintains zero-tolerance marijuana policies in compliance with federal DOT regulations. The Puget Sound region's transit agencies reported recruitment challenges for bus operators, with some candidates declining positions after learning of permanent marijuana restrictions.

Oregon

Oregon legalized medical marijuana in 1998 and recreational marijuana in 2014. Oregon law provides limited employment protections for medical marijuana cardholders under ORS 659A.885, but these protections explicitly do not apply to positions requiring federal licensing or certification, exempting DOT-regulated workers. Oregon trucking companies and airlines operating from Portland International Airport maintain federal testing requirements despite state legalization.

New York

New York legalized recreational marijuana through the Marijuana Regulation and Taxation Act in March 2021. The law includes employment protections prohibiting discrimination based on off-duty marijuana use, but Section 201-d(4-a) explicitly exempts positions where federal law requires drug testing. DOT-regulated employers in New York continue mandatory marijuana testing for pilots, commercial drivers, and railroad workers. The Metropolitan Transportation Authority, operating New York City's subway and bus systems, maintains zero-tolerance policies for marijuana use by safety-sensitive employees.

Florida

Florida has legalized medical marijuana but not recreational use as of May 2026. Florida's medical marijuana law, codified in Florida Statutes § 381.986, does not require employers to accommodate medical marijuana use and explicitly states that employers may enforce drug-free workplace policies. Florida's large aviation industry—including major airline operations in Miami, Fort Lauderdale, Orlando, and Tampa—maintains strict marijuana testing in compliance with FAA regulations.

Texas

Texas has limited medical marijuana through its Compassionate Use Program but has not legalized recreational marijuana. Texas law provides no employment protections for marijuana use, and the state's large trucking industry strictly enforces federal DOT testing requirements. The Texas Department of Transportation reported that marijuana violations represented 71% of drug testing failures among commercial drivers in 2024, the highest percentage among large states.

Illinois

Illinois legalized recreational marijuana in January 2020 through the Cannabis Regulation and Tax Act. The law includes employment protections prohibiting discrimination based on off-duty marijuana use, but Section 10-50(e) exempts positions subject to federal background checks, drug testing, or other federal requirements. Chicago's aviation industry and freight rail operations maintain federal testing requirements despite state legalization.

Market and Business Implications

The conflict between DOT marijuana rules and state legalization creates measurable economic costs through workforce shortages, recruitment challenges, and operational constraints across transportation sectors. The American Trucking Associations estimated in 2025 that the driver shortage cost the industry $94 billion annually in delayed shipments, increased wages, and operational inefficiencies. While multiple factors contribute to driver shortages, drug testing failures—predominantly for marijuana—eliminate approximately 88,000 potential drivers annually from the workforce. The average cost to recruit, hire, and train a commercial driver ranges from $8,000 to $12,000, meaning marijuana-related testing failures represent $700 million to $1 billion in wasted recruitment investment annually. Airlines face similar recruitment pressures. The Regional Airline Association reported in 2024 that 19% of pilot candidates who began training programs withdrew before completion, with post-training surveys indicating that lifestyle restrictions, including permanent marijuana prohibition, influenced decisions to leave aviation careers. The cost to train a commercial pilot from zero experience to airline transport pilot certification averages $150,000-$200,000, making candidate attrition economically significant. Testing and compliance costs represent another business impact. DOT-regulated employers spent approximately $1.8 billion on drug and alcohol testing in 2024, according to industry estimates. This includes laboratory testing fees ($35-$75 per test), Medical Review Officer services ($25-$50 per test), collection site fees ($30-$60 per test), and administrative costs. Random testing requirements—50% of safety-sensitive employees annually for drugs—drive the majority of testing volume. The Drug and Alcohol Clearinghouse created additional costs for motor carriers. FMCSA requires employers to conduct full queries of all drivers annually and limited queries before hiring, with each query costing $1.25. For large carriers with thousands of drivers, annual clearinghouse costs exceed $100,000. The clearinghouse has also increased liability exposure; employers who fail to query the database before hiring drivers with violation records face potential negligence claims if those drivers are involved in accidents. Insurance implications affect companies across transportation sectors. Insurers consider drug testing programs when underwriting commercial auto, aviation, and general liability policies. Companies with higher-than-average positive test rates may face premium increases or coverage restrictions. Conversely, robust testing programs can qualify companies for premium discounts, creating financial incentives to maintain strict marijuana policies beyond regulatory requirements. Labor relations costs have increased as unions challenge marijuana policies through grievance procedures and collective bargaining. While arbitrators consistently uphold terminations for positive marijuana tests when DOT regulations apply, the grievance process itself imposes costs—legal fees, arbitrator fees, and management time—that companies must absorb. Some carriers have reported spending $50,000-$150,000 annually defending marijuana-related grievances.

What Experts Say

Transportation safety researchers, labor economists, and drug policy experts offer divergent perspectives on whether current DOT marijuana rules appropriately balance safety and workforce needs. The National Transportation Safety Board has maintained that marijuana impairment poses legitimate safety risks in transportation operations. According to NTSB accident investigations, marijuana has been identified as a contributing factor in multiple serious transportation accidents, including a 2016 Hoboken, New Jersey commuter train crash that killed one person and injured 114, where the engineer tested positive for marijuana. NTSB Chairman Jennifer Homendy has stated that the agency supports continued marijuana testing for safety-sensitive positions until reliable impairment testing becomes available. The National Institute on Drug Abuse has documented that marijuana affects cognitive and motor functions relevant to transportation safety, including reaction time, coordination, divided attention, and lane tracking. NIDA research indicates that impairment is most significant in the first 2-4 hours after use but that residual effects may persist longer. However, NIDA has also acknowledged that current urine testing for THC metabolites cannot determine when marijuana was used or whether an individual was impaired at a specific time, only that use occurred within the detection window of approximately 3-30 days. Labor economists have analyzed marijuana testing's impact on workforce participation. A 2024 study published in the Journal of Labor Economics found that states legalizing recreational marijuana experienced 8-12% increases in commercial driver license testing failures, with corresponding impacts on driver availability. The researchers estimated that eliminating marijuana testing for commercial drivers could expand the available workforce by 6-9%, though they noted this analysis did not account for potential safety impacts. The American Civil Liberties Union has argued that DOT marijuana policies disproportionately affect workers of color and constitute employment discrimination without valid safety justification. ACLU analysis of FMCSA clearinghouse data found that Black and Hispanic drivers were overrepresented among marijuana violations relative to their proportion of the CDL holder population, though the organization acknowledged that testing procedures themselves are race-neutral and that disparities may reflect broader patterns in marijuana use and enforcement. Drug testing industry representatives have noted that alternative testing methods—including oral fluid testing, which detects more recent marijuana use than urine testing—could address some concerns about detection windows. The Substance Abuse and Mental Health Services Administration approved oral fluid testing for federal workplace drug testing programs in 2019, and DOT has proposed incorporating oral fluid testing as an option under Part 40 regulations. However, oral fluid testing still cannot definitively establish impairment at a specific time, only that use occurred within approximately 12-24 hours. Substance abuse professionals who evaluate transportation workers following positive drug tests have reported that many individuals testing positive for marijuana do not meet clinical criteria for cannabis use disorder. According to the National Association of Substance Abuse Professionals, approximately 60% of DOT-regulated employees who test positive for marijuana in random or post-accident testing are assessed as low-risk users who do not require intensive treatment. These professionals have questioned whether termination is an appropriate response for off-duty marijuana use by otherwise safe and competent workers.

What's Next

DOT marijuana employment rules are unlikely to change without Congressional action or DEA rescheduling of cannabis, neither of which appears imminent as of May 2026. The Drug Enforcement Administration's review of marijuana scheduling, initiated in 2022 following President Biden's directive, remains ongoing as of May 2026. If the DEA were to reschedule marijuana from Schedule I to Schedule III or lower under the Controlled Substances Act, DOT would need to reassess its testing requirements. However, rescheduling would not automatically eliminate marijuana from DOT testing panels; the agency would need to conduct rulemaking to modify 49 CFR Part 40, a process requiring notice, public comment, and final rule publication that typically takes 18-36 months. Congressional legislation could directly address DOT marijuana policies. Several bills introduced in the 118th and 119th Congresses proposed modifications to transportation drug testing, including the SAFE Banking Act and the MORE Act, but none specifically addressed DOT employment rules. Labor organizations have advocated for legislation that would require DOT to develop impairment-based testing rather than metabolite detection, but no such bills have advanced through committee as of May 2026. Technological developments in marijuana impairment testing could influence future policy. Several companies are developing devices to detect THC in breath or saliva at levels correlated with recent use and potential impairment, similar to alcohol breathalyzers. If such devices achieve scientific validation and regulatory approval, DOT could potentially adopt impairment testing standards that would permit off-duty marijuana use while prohibiting on-duty impairment. However, as of May 2026, no marijuana impairment testing device has received DOT approval for workplace use. State-level employment protections for marijuana use continue to expand, but these laws consistently exempt DOT-regulated positions. New York, New Jersey, Connecticut, Montana, and Nevada have enacted laws prohibiting employment discrimination based on off-duty marijuana use, but all include exceptions for positions requiring federal drug testing. Future state legislation is expected to follow this pattern, maintaining the federal-state divide for transportation workers. Labor arbitration and collective bargaining may produce incremental changes in how employers handle positive marijuana tests. Some unions have negotiated provisions allowing employees who test positive for marijuana to enter treatment programs and return to work rather than face automatic termination, though such provisions still require compliance with DOT return-to-duty procedures. These negotiated alternatives do not change testing requirements but may provide pathways to continued employment for some workers. The Federal Aviation Administration's medical certification process for pilots may see reforms related to marijuana. The agency has faced pressure to modernize policies given that many medications now legal and widely prescribed—including some opioids and benzodiazepines—are permitted for pilots under specific conditions, while marijuana remains absolutely prohibited. However, FAA has indicated that marijuana policy changes would require coordination with DOT and would not occur independently of broader federal drug policy reforms. Industry workforce pressures may eventually force policy reconsideration. If driver shortages continue to worsen and marijuana testing is identified as a significant contributing factor, Congress may face pressure from business groups to modify DOT rules. The American Trucking Associations has not formally advocated for marijuana policy changes as of May 2026 but has acknowledged that testing requirements affect driver availability.

Further Reading

• 49 CFR Part 40 - Procedures for Transportation Workplace Drug and Alcohol Testing Programs (full regulatory text): https://www.ecfr.gov/current/title-49/subtitle-A/part-40
• Department of Transportation Office of Drug and Alcohol Policy and Compliance official guidance: https://www.transportation.gov/odapc
• Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse: https://clearinghouse.fmcsa.dot.gov/
• Federal Aviation Administration Drug Abatement Program information: https://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/drug_alcohol/
• Omnibus Transportation Employee Testing Act of 1991, Public Law 102-143: https://www.congress.gov/bill/102nd-congress/house-bill/2942
• Controlled Substances Act, 21 U.S.C. § 801 et seq.: https://www.govinfo.gov/content/pkg/USCODE-2021-title21/pdf/USCODE-2021-title21-chap13.pdf
• National Transportation Safety Board accident investigation reports: https://www.ntsb.gov/investigations/
• Substance Abuse and Mental Health Services Administration workplace drug testing guidance: https://www.samhsa.gov/workplace
• American Trucking Associations driver shortage analysis: https://www.trucking.org/economics-and-industry-data
• Association of Flight Attendants-CWA policy positions: https://www.afacwa.org/